Literature DB >> 12654849

Th2 responses predominate during the early phases of infection in patients with localized cutaneous leishmaniasis and precede the development of Th1 responses.

Eliane Bourreau1, Jacques Gardon, Roger Pradinaud, Hervé Pascalis, Ghislaine Prévot-Linguet, Amina Kariminia, Launois Pascal.   

Abstract

Intralesional Th2 responses preceded the development of Th1 responses in localized cutaneous leishmaniasis due to Leishmania guyanensis. Although the number of parasites increased in Th2 lesions, no correlation was found between the levels of cytokine expression and the number of parasites. In contrast, the decreased number of parasites in Th1 lesions is negatively correlated to gamma interferon expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654849      PMCID: PMC152072          DOI: 10.1128/IAI.71.4.2244-2246.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice.

Authors:  T Biedermann; S Zimmermann; H Himmelrich; A Gumy; O Egeter; A K Sakrauski; I Seegmüller; H Voigt; P Launois; A D Levine; H Wagner; K Heeg; J A Louis; M Röcken
Journal:  Nat Immunol       Date:  2001-11       Impact factor: 25.606

Review 2.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

Review 3.  Functional diversity of helper T lymphocytes.

Authors:  A K Abbas; K M Murphy; A Sher
Journal:  Nature       Date:  1996-10-31       Impact factor: 49.962

4.  Interleukin (IL)-13 is the predominant Th2 cytokine in localized cutaneous leishmaniasis lesions and renders specific CD4+ T cells unresponsive to IL-12.

Authors:  E Bourreau; G Prévot; R Pradinaud; P Launois
Journal:  J Infect Dis       Date:  2001-02-09       Impact factor: 5.226

5.  Immunologic determinants of disease evolution in localized cutaneous leishmaniasis due to Leishmania major.

Authors:  H Louzir; P C Melby; A Ben Salah; H Marrakchi; K Aoun; R Ben Ismail; K Dellagi
Journal:  J Infect Dis       Date:  1998-06       Impact factor: 5.226

6.  Evaluation of a direct immunofluorescent antibody (DIFMA) test using Leishmania genus-specific monoclonal antibody in the routine diagnosis of cutaneous leishmaniasis.

Authors:  M E Chico; R H Guderian; P J Cooper; R Armijos; M Grogl
Journal:  Rev Soc Bras Med Trop       Date:  1995 Apr-Jun       Impact factor: 1.581

7.  Macrophage activation by interferon-gamma from host-protective T cells is inhibited by interleukin (IL)3 and IL4 produced by disease-promoting T cells in leishmaniasis.

Authors:  F Y Liew; S Millott; Y Li; R Lelchuk; W L Chan; H Ziltener
Journal:  Eur J Immunol       Date:  1989-07       Impact factor: 5.532

Review 8.  The regulation of immunity to Leishmania major.

Authors:  S L Reiner; R M Locksley
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

9.  Cytokine patterns in the pathogenesis of human leishmaniasis.

Authors:  C Pirmez; M Yamamura; K Uyemura; M Paes-Oliveira; F Conceição-Silva; R L Modlin
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

10.  Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction.

Authors:  G Cáceres-Dittmar; F J Tapia; M A Sánchez; M Yamamura; K Uyemura; R L Modlin; B R Bloom; J Convit
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

View more
  9 in total

1.  Th1/Th2 cytokine profile in patients coinfected with HIV and Leishmania in Brazil.

Authors:  Maria Zilma Andrade Rodrigues; Maria Fernanda Rios Grassi; Sanjay Mehta; Xing-Quan Zhang; Luana Leandro Gois; Robert T Schooley; Roberto Badaro
Journal:  Clin Vaccine Immunol       Date:  2011-08-10

2.  [Cutaneous leishmaniasis].

Authors:  E von Stebut; C Sunderkötter
Journal:  Hautarzt       Date:  2007-05       Impact factor: 0.751

3.  Decreased memory T-cell response and function in human immunodeficiency virus-infected patients with tegumentary leishmaniasis.

Authors:  Luana Leandro Gois; Sanjay Mehta; Maria Zilma Andrade Rodrigues; Robert T Schooley; Roberto Badaró; Maria Fernanda Rios Grassi
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-10-02       Impact factor: 2.743

4.  Comparative immune study on cutaneous leishmaniasis patients with single and multiple sores.

Authors:  Ban Noori Al-Qadhi; Israa Salim Musa; Yassir Mustafa Kamal Al-Mulla Hummadi
Journal:  J Parasit Dis       Date:  2013-11-21

5.  Intralesional regulatory T-cell suppressive function during human acute and chronic cutaneous leishmaniasis due to Leishmania guyanensis.

Authors:  E Bourreau; C Ronet; E Darcissac; M C Lise; D Sainte Marie; E Clity; F Tacchini-Cottier; P Couppie; P Launois
Journal:  Infect Immun       Date:  2009-01-21       Impact factor: 3.441

6.  Outbreak of Cutaneous Leishmaniasis in Peruvian Military Personnel Undertaking Training Activities in the Amazon Basin, 2010.

Authors:  Marianela Oré; Eliana Sáenz; Rufino Cabrera; Juan F Sanchez; Maxy B De Los Santos; Carmen M Lucas; Jorge H Núñez; Kimberly A Edgel; Justino Sopan; Jorge Fernández; Andres M Carnero; G Christian Baldeviano; Juan C Arrasco; Paul C F Graf; Andres G Lescano
Journal:  Am J Trop Med Hyg       Date:  2015-06-15       Impact factor: 2.345

7.  Polymorphisms in the TOLLIP Gene Influence Susceptibility to Cutaneous Leishmaniasis Caused by Leishmania guyanensis in the Amazonas State of Brazil.

Authors:  Felipe Jules de Araujo; Luan Diego Oliveira da Silva; Tirza Gabrielle Mesquita; Suzana Kanawati Pinheiro; Wonei de Seixas Vital; Anette Chrusciak-Talhari; Jorge Augusto de Oliveira Guerra; Sinésio Talhari; Rajendranath Ramasawmy
Journal:  PLoS Negl Trop Dis       Date:  2015-06-24

Review 8.  Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting.

Authors:  Sreedhar Amere Subbarao
Journal:  Inflammopharmacology       Date:  2021-03-15       Impact factor: 5.093

9.  Monarch-1 Activation in Murine Macrophage Cell Line (J774 A.1) Infected with Iranian Strain of Leishmania major.

Authors:  A Fata; Mr Mahmoudian; A Varasteh; M Sankian
Journal:  Iran J Parasitol       Date:  2013-04       Impact factor: 1.012

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.